Innovations in Pharmaceutical Technology (IPT)
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.
Install App?
Innovations in Pharmaceutical Technology (IPT)
www.iptonline.com
This is how the Install App dialog will look like once your App goes live.
Francis Dechoux will focus on growth opportunities across the EMEA region
Flexible containment specialist ONFAB, part of the Envair Technology group, has appointed Francis Dechoux as its new European Business Lead.
Francis will support ONFAB’s continuing growth within the pharmaceutical industry focussing on key European territories, including France, Germany, and Spain.
His role will see him take a strategic lead, helping to raise awareness and acceptance of ONFAB’s transformational flexible containment technology within the industry.
Fluent in three languages, Francis has over 30 years of experience working in business development roles with global manufacturers, mainly in the automotive industry at Mitras Automotive.
Francis said: “It’s an exciting time to be joining ONFAB. The level of growth the business is experiencing across Europe is impressive. I’m looking forward to working with customers to help them take advantage of its innovative containment solutions.”
Mark Arnold, Managing Director of ONFAB said: “With more pharmaceutical businesses using highly potent compounds, we’re seeing a huge growth in demand for flexible containment that will protect operators and prevent cross-contamination. Francis’s wealth of experience in supporting global manufacturers will be valuable as we look to onboard an increasing number of customers in Europe.”
About Envair Technology
Envair Technology was formed following the acquisition of Envair Limited by ONFAB in 2019 and Total Containment Solutions (TCS) in 2020. The group brings world class design and manufacturing expertise in clean air and containment to organisations developing or manufacturing drugs and new therapies around the world.
Working with hospitals and healthcare settings, pharmaceutical firms and R&D laboratories, the group offers a wide portfolio of products and services that protect the safety of teams handling hazardous compounds and maintain the integrity of pharmaceutical products. www.envairtechnology.com.
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/b2fdfcd9-5174-45b6-8d1d-9b641ad7095a.png?optimizer=image&width=360&aspect_ratio=3:4)
Austrian State Secretary to speak at FlyPharma Europe 2023
29 September 2023 -- London, UK -- FlyPharma Europe will welcome Mr Florian Tursky, the Austrian state secretary, to the conference on 10 October, where he will deliver an opening speech. He will join a host of expert industry speakers from both pharma and cargo sectors
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/e27828aa-7431-445b-8b52-d6d3b9228649.png?optimizer=image&width=360&aspect_ratio=3:4)
Revvity Expands Access to Base Editing Technology with Aim to Accelerate Discovery to Cure
26 September 2023 -- Massachusetts, US -- Revvity unveils its groundbreaking Pin-point base editing platform reagents, providing researchers with unparalleled access to implement the advanced gene editing technique in their preclinical laboratories
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/589e2bd7-77cb-43d6-ac4a-f0180b72bb89.png?optimizer=image&width=360&aspect_ratio=3:4)
Cellectricon Expands Neuroscience Contract Research Portfolio with New Neuroplasticity Services
26 September 2023 -- Molndal, Sweden -- Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, announced the launch of a new service module for neuroplasticity research
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/3d896106-9683-4d84-b2bf-6db473ad2a53.png?optimizer=image&width=360&aspect_ratio=3:4)
Start Codon Invites Life Sciences Leaders, Founders and Investors to Innovation Showcase 2023
26 September 2023 -- Cambridge, UK -- Start Codon, a life science and healthcare venture-building fund, is pleased to invite life sciences leaders, entrepreneurs and investors from across the life science and biotech industries to attend their Innovation Showcase 2023
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/a568048c-8b7a-4d2e-9778-6f3a80fa8220.png?optimizer=image&width=360&aspect_ratio=3:4)
Evonetix Unveils New Branding to Align with its Vision for Gene-length DNA Synthesis
26 September 2023 -- Cambridge, UK -- Evonetix, the Company developing semiconductor scale technology to improve access to gene synthesis, announces the introduction of new branding to align with its vision to ‘Redefine possible’ through the development and commercialisation of its benchtop semiconductor gene synthesis platform
1
Human-Centred Design: From Inception to Integration
IPT sat down with Dr Chris Vincent at PDD, to understand more about the digital innovations that are leading design and whether technologies like Extended Reality (XR) can be beneficial to the process
2
The Importance of Temperature Control in Pharmaceutical Analysis
As technology within the analysis sphere continues to evolve, temperature control is becoming increasingly important for drug discovery and research
3
Providing Support Throughout the Patient Journey
Concierge services are critical to helping patients navigate technology and other logistics in a decentralised clinical trial. How best can they be implemented?
